PLoS ONE (Jan 2013)

The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression.

  • Lin Liu,
  • Jing Nie,
  • Lin Chen,
  • Guanglong Dong,
  • Xiaohui Du,
  • Xin Wu,
  • Yun Tang,
  • Weidong Han

DOI
https://doi.org/10.1371/journal.pone.0055532
Journal volume & issue
Vol. 8, no. 2
p. e55532

Abstract

Read online

Transforming growth factor (TGF)-β/Smad signaling plays an important role in colon cancer development, progression and metastasis. In this study we demonstrated that the microRNA-130a/301a/454 family is up-regulated in colon cancer tissues compared to paired adjacent normal mucosa, which share the same 3'-untranslational region (3'-UTR) binding seed sequence and are predicated to target Smad4. In colorectal cancer HCT116 and SW480 cells, overexpression of miRNA-130a/301a/454 mimics enhances cell proliferation and migration, while inhibitors of these miRNAs affect cell survival. The biological function of miRNA-130a/301a/454 on colon cancer cells is likely mediated by suppression of Smad4, and the up-regulation of the miRNAs is correlated with Smad4 down-regulation in human colon cancers. Collectively, these results suggest that miRNA-130a/301a/454 are novel oncogenic miRNAs contributing to colon tumorigenesis by regulating TGF-β/Smad signaling, which may have potential application in cancer therapy.